美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=DEXTROSE 2.5% IN PLASTIC CONTAINER"
符合检索条件的记录共27
3 页 当前第 3 页  首页 上一页 返回检索页
21药品名称DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
申请号019631产品号004
活性成分DEXTROSE; SODIUM CHLORIDE市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格2.5GM/100ML;450MG/100ML
治疗等效代码AP参比药物
批准日期1988/02/24申请机构B BRAUN MEDICAL INC
22药品名称DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
申请号019631产品号005
活性成分DEXTROSE; SODIUM CHLORIDE市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格2.5GM/100ML;900MG/100ML
治疗等效代码参比药物
批准日期1988/02/24申请机构B BRAUN MEDICAL INC
23药品名称DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER
申请号019634产品号001
活性成分CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格10MG/100ML;2.5GM/100ML;15MG/100ML;300MG/100ML;160MG/100ML
治疗等效代码参比药物
批准日期1988/02/24申请机构B BRAUN MEDICAL INC
24药品名称DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
申请号020163产品号002
活性成分CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE市场状态处方药
剂型或给药途径SOLUTION;INTRAPERITONEAL规格25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML
治疗等效代码AT参比药物
批准日期1992/12/04申请机构BAXTER HEALTHCARE CORP
25药品名称DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER
申请号020171产品号002
活性成分CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE市场状态处方药
剂型或给药途径SOLUTION;INTRAPERITONEAL规格18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML
治疗等效代码AT参比药物
批准日期1992/08/19申请机构FRESENIUS MEDICAL CARE NORTH AMERICA
26药品名称DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
申请号020183产品号002
活性成分CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE市场状态处方药
剂型或给药途径SOLUTION;INTRAPERITONEAL规格18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML
治疗等效代码参比药物
批准日期1992/12/04申请机构BAXTER HEALTHCARE CORP
27药品名称INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
申请号020374产品号002
活性成分CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE市场状态停止上市
剂型或给药途径SOLUTION;INTRAPERITONEAL规格18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML
治疗等效代码参比药物
批准日期1994/06/13申请机构FRESENIUS USA INC